SCHEMBL6173690

SCHEMBL6173690

COc1cnccc1C(C)C1(C(C)c2ccncc2OC)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.41
GAA P10253 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MCHR1 Q99705 3/20 0.35
NPBWR1 P48145 2/20 0.35
AR P10275 2/20 0.34
MMP13 P45452 1/20 0.34
MAPT P10636 1/20 0.34
ABL1 P00519 2/20 0.33
P2RX3 P56373 1/20 0.33
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
LIPE Q05469 1/20 0.32
KDM4C Q9H3R0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2941010 0.90 CYP3A4 (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172003 0.89 ALDH1A1 (0.37) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173429 0.88 POLB (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174506 0.87 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175704 0.85 POLB (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173283 0.85 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172522 0.85 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173440 0.85 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175486 0.84 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174812 0.84 ALDH1A1 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed